L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, bimol. cyclic (1→1'),(6→6')-bis(disulfide)
- Product Name
- L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, bimol. cyclic (1→1'),(6→6')-bis(disulfide)
- CAS No.
- 1505451-00-2
- Chemical Name
- L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, bimol. cyclic (1→1'),(6→6')-bis(disulfide)
- Synonyms
- Eptifibatide Impurity 14;Eptifibatide Dimer (10 mg);L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, bimol. cyclic (1→1'),(6→6')-bis(disulfide)
- CBNumber
- CB711126648
- Molecular Formula
- C70H98N22O18S4
- Formula Weight
- 1663.93
- MOL File
- 1505451-00-2.mol
More
Less
L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, bimol. cyclic (1→1'),(6→6')-bis(disulfide) Property
- Density
- 1.61±0.1 g/cm3(Predicted)
- pka
- 3.71±0.10(Predicted)
L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, bimol. cyclic (1→1'),(6→6')-bis(disulfide) Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, bimol. cyclic (1→1'),(6→6')-bis(disulfide) Suppliers
- Tel
- 18913906212
- 2885426135@qq.com
- Country
- China
- ProdList
- 6427
- Advantage
- 58
- Tel
- 18162595016
- 3287908757@qq.com
- Country
- China
- ProdList
- 9887
- Advantage
- 58
- Tel
- 18924305345
- LK@zlstandards.com
- Country
- China
- ProdList
- 6348
- Advantage
- 58
1505451-00-2, L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, bimol. cyclic (1→1'),(6→6')-bis(disulfide)Related Search:
L-Aspartic acid, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-, (1→3')-disulfide with L-tryptophyl-L-prolyl-L-cysteinamide (9CI)
Eptifibatide impurity 3/Deamidated Eptifibatide Impurity/(3R,11S,17S,20S,25aS)-20-((1H-indol-3-yl)Methyl)-17-(carboxymethyl)-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-1H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosine-3-carbo
Cyclo(L-Pro-L-Trp-)
N-[2-(Phenylmethyl)phenyl]-2-chloroacetamide
Acetamide, 2-methoxy-N-[2-(phenylmethyl)phenyl]-
Methanone, (2-aminophenyl)phenyl-, hydrazone, (Z)-
L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→7)-disulfide (9CI)
Benzamide, N-[(6,11-dihydro-5H-dibenz[b,e]azepin-6-yl)methyl]-2-(hydroxymethyl)-
7-Bromo Epinastine
Eptifibatide non cyclic impurity
3'-Hydroxyacetophenone
6-Chloromethylmorphanthridine
Acetamide, 2-(1-methylethoxy)-N-[2-(phenylmethyl)phenyl]-